Colorectal Cancer Screening French Organizations for the Follow-up After Colonoscopy

NCT ID: NCT03383367

Last Updated: 2017-12-26

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 33000 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2017-08-24
• Study Completion Date: 2018-12-31

Brief Summary

France is one of the European countries where the incidence of colorectal cancer is the highest among cancers for both sexes. Fecal occult blood screening has been implemented since 2008. However, this screening excludes high risk people who have a 10 to 30 % risk of developing a CRC during their lifetime. Colonoscopy follow up of these persons is not organized, and it is up to the attending physician to recall the date of the surveillance colonoscopy. This results in a poor compliance with the recommendations by these people. A postal reminder of the surveillance colonoscopies sent by The French screening organizations to the patients should increase adherence to follow-up recommendations. The colorectal cancer screening organizations will collects from the hepatogastroenterologists (HGE) informations on colonoscopies of people more than 50 years old who live in the Rhone. These informations will allow to send a reminder 3 months before the date recommended by the HGE. Participation rate and timeliness will be assessed, as well as the severity of the lesions found. A medico-economic analysis will also be carried out.

Conditions

Colorectal Cancer

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: SCREENING
• Blinding Strategy: NONE

Study Groups

Tempo Colo

Group Type: EXPERIMENTAL

Tempo Colo

Intervention Type: BEHAVIORAL

Reminder letter for people at high risk of colorectal cancer.

Interventions

Tempo Colo

Reminder letter for people at high risk of colorectal cancer.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• people aged 50 years or more ;
• at high risk of colorectal cancer ;
• living in Rhône administrative departement or Metropolitan Lyon

Exclusion Criteria

• person with chronic inflammatory bowel disease
• colorectal cancer in diagnosis or treatment period

• Minimum Eligible Age: 50 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

National Cancer Institute, France

OTHER_GOV

Sponsor Role: collaborator

Association pour le Dépistage Organisé des Cancers dans le Rhône

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Adémas-69

Lyon, Rhône, France

Countries

France

Other Identifiers

2016-A01710-51

Identifier Type: -

Identifier Source: org_study_id